Clinical Trials Browser

Phase 3 × INDUSTRY × Control Groups × Clear all

NCT02870582 2022-11-29

Donafenib for Previously Treated Metastatic Colorectal Cancer

Phase 3 Completed

Gastrointestinal

Colorectal Neoplasms